Menten AI Company
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Investors
Connections from
Founded Date:
2018-08-24
Technology:
['BioTech & HealthTech', 'AI Infrastructure']
Investor Type:
info@menten.ai
Funding Status:
Seed
Total Funding:
4005000.0
Employee Number:
1-10
Headquarters:
Palo Alto, California, United States
Last Funding Date:
2020-06-30
Investors Number:
6.0
Last Funding Type:
Seed
Industry:
Medical BioTech